Top news of the week: 07.04.2020.
#lifesciences #pharmaceuticals #biotechnology #biospace #CoronaPandemic #COVID19 #CoronaOutbreak #CoronaVirus #biopharma #20under40
Career And Jobs
Biopharma Update on the Novel Coronavirus: March 31
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/ujCBiVI0pt
OpenBiopharma Update on the Novel Coronavirus: March 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.
Biopharma Update on the Novel Coronavirus: April 1
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/W9sSk5Rno6
OpenBiopharma Update on the Novel Coronavirus: April 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 1, 2020.
The 20 under 40: Inside the next generation of #biopharma leaders https://t.co/pJ1QBLiaMh @endpts
OpenThe 20 under 40: Inside the next generation of biopharma leaders
“Each generation needs a new music,” Francis Crick wrote in 1988, reflecting back on his landmark discovery. Crick was 35, then, in 1953, when he began working with a 23-year-old named ...
Biopharma equities start to recover as financial markets stabilize
After plunging dramatically at the beginning of the month, biopharmaceutical equities appear to be recovering some of the valuation they originally lost when the financial markets cratered. ...
In Other (Biopharma) News: Non-Coronavirus Stories this Week
#biospace #lifesciences #biotechnology #pharmaceuticals
https://t.co/KoZ5vxwMPt
OpenIn Other (Biopharma) News: Non-Coronavirus Stories this Week
The following is a roundup of some of this week's non-coronavirus biopharma news.
Close to $4B in 5 days --
Another day, another boatload for biotech. Deerfield adds $840M to rush of venture dollars
By @Jasonmmast
https://t.co/2pBLFYZDn4
OpenAnother day, another boatload for biotech. Deerfield adds $840M to rush of venture dollars
The biotech dollars just keep rolling in. Even as the world economy faces an economic contraction unprecedented in nature, biotech venture capital firms are announcing huge new investment ...
In April, we spoke with Yohan Tessier of @misprobiotech about the great work they're doing to advance #LifeSciences. Learn how Mispro is cultivating innovation in science through a coworking #vivarium & how it’s enabling #DrugDiscovery: https://t.co/nuK70zo2ck #MemberSpotlight https://t.co/bgxA4s6QGn
OpenMember Spotlight: Q&A with Mispro Biotech Services
Yohan has been on the forefront of Mispro’s growth from a single facility to becoming North America’s leading contract vivarium company with facilities in all major U.S. biotech …
7 Biotech Stocks to Buy for a Post-Pandemic World
Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics